These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 20368010)
21. Oromandibular dystonia: differential diagnosis and management. Khan J; Anwer HM; Eliav E; Heir G J Am Dent Assoc; 2015 Sep; 146(9):690-3. PubMed ID: 26314978 [No Abstract] [Full Text] [Related]
22. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Tan EK; Lo YL; Seah A; Auchus AP J Neurol Sci; 2001 Sep; 190(1-2):95-7. PubMed ID: 11574113 [TBL] [Abstract][Full Text] [Related]
23. Clinical use of botulinum toxins in oral and maxillofacial surgery. Majid OW Int J Oral Maxillofac Surg; 2010 Mar; 39(3):197-207. PubMed ID: 19959337 [TBL] [Abstract][Full Text] [Related]
24. [Neurogenic temporomandibular joint dislocation. Definition and therapy with botulinum toxin]. Daelen B; Thorwirth V; Koch A Nervenarzt; 1997 Apr; 68(4):346-50. PubMed ID: 9273466 [TBL] [Abstract][Full Text] [Related]
25. Severe amphethamine-induced bruxism: treatment with botulinum toxin. See SJ; Tan EK Acta Neurol Scand; 2003 Feb; 107(2):161-3. PubMed ID: 12580870 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630 [No Abstract] [Full Text] [Related]
28. [Treatment of sialorrhea with botulinum toxin: an overview]. Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912 [TBL] [Abstract][Full Text] [Related]
29. New therapeutic indications for botulinum toxins. Cordivari C; Misra VP; Catania S; Lees AJ Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin as an adjunct for the treatment of acute anteromedial arytenoid dislocation. Rontal E; Rontal M Laryngoscope; 1999 Jan; 109(1):164-6. PubMed ID: 9917060 [No Abstract] [Full Text] [Related]
31. The effects of botulinum toxin on ocular tissue. Smith H Nurs Times; 1995 Jan 25-31; 91(4):41-3. PubMed ID: 7862573 [TBL] [Abstract][Full Text] [Related]
32. [Treatment with botulinum toxin in neurologic pediatrics]. Justus N; Lee SH; Berweck S; Heinen F Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921 [No Abstract] [Full Text] [Related]
33. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Tan EK Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600 [TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin B reduces sialorrhea in parkinsonism. Racette BA; Good L; Sagitto S; Perlmutter JS Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678 [TBL] [Abstract][Full Text] [Related]
36. Treatment of bruxism in Huntington's disease with botulinum toxin. Nash MC; Ferrell RB; Lombardo MA; Williams RB J Neuropsychiatry Clin Neurosci; 2004; 16(3):381-2. PubMed ID: 15377749 [No Abstract] [Full Text] [Related]
37. Botulinum toxin and dystonias. Drug Ther Bull; 1991 Dec; 29(26):102-3. PubMed ID: 1790760 [No Abstract] [Full Text] [Related]
38. Botulinum toxin type B for sialorrhea in children with cerebral palsy. Reddihough D; Graham HK Dev Med Child Neurol; 2011 Jun; 53(6):488-9. PubMed ID: 21501158 [No Abstract] [Full Text] [Related]